Identification of Hepatic Dendritic Cells in Liver Biopsies Showing Steatosis in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Associated with Obesity

Beatriz Barranco-Fragoso; Shreya C. Pal; Luis E. Díaz-Orozco; Rita Dorantes-Heredia; Xingshun Qi; Nahum Méndez-Sánchez

doi:10.12659/MSM.937528

08 August 2022 : Clinical Research

Identification of Hepatic Dendritic Cells in Liver Biopsies Showing Steatosis in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Associated with Obesity

Beatriz Barranco-Fragoso^12ABC, Shreya C. Pal

^34CDEFG, Luis E. Díaz-Orozco

^34ABCDEF, Rita Dorantes-Heredia

^5BCD, Xingshun Qi^6F, Nahum Méndez-Sánchez

^34ACDEF*

DOI: 10.12659/MSM.937528

Med Sci Monit 2022; 28:e937528

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 4 Increased hepatic dendritic cells (CD11c+, hDCs) expression in liver tissue according to patient’s body mass index (BMI)A graphic/schematic distribution of the liver expression of hDCs (CD11c+) according to patients’ BMI. Hematoxylin and Eosin (H), and Masson trichrome stains in liver biopsy form patients with different BMIs. Liver expression of hDCs (CD11c+) according to patients’ BMI.

Back to the Article

Identification of Hepatic Dendritic Cells in Liver Biopsies Showing Steatosis in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Associated with Obesity

Your Privacy